Home › Funds › Kimelman & Baird, LLC › ABBV

Kimelman & Baird, LLC position in ABBV

ABBVIE INC · Health Care

Kimelman & Baird, LLC reported holding 30,556 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 0.60% of its reported portfolio and ranking #39 among its reported holdings. Kimelman & Baird, LLC has disclosed ABBV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)30.56K sh
Reported value held$7.99M
Portfolio Weight0.60%
First reportedQ2 2024
Last changeHold
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How Kimelman & Baird, LLC's ABBV position evolved

Kimelman & Baird, LLC first disclosed a stake in ABBV in Q2 2024 at 33,766 shares (US$5.8M). The position peaked in Q3 2026 at 30,556 shares, worth US$8.0M. Across 10 filings, Kimelman & Baird, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 30,556 shares valued at US$8.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 33.77K $5.79M New
Q3 2024 33.77K $6.67M Hold
Q4 2024 31.07K $5.52M Reduce
Q1 2025 31.07K $6.51M Hold
Q2 2025 31.07K $5.77M Hold
Q3 2025 31.07K $7.19M Hold
Q4 2025 30.66K $7.00M Reduce
Q1 2026 30.66K $6.67M Hold
Q2 2026 30.66K $7.71M Hold
Q3 2026 30.56K $7.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Kimelman & Baird, LLC held ABBV?

Kimelman & Baird, LLC has disclosed ABBV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Kimelman & Baird, LLC's current position in ABBV?

As of Q3 2026, Kimelman & Baird, LLC holds 30.56K shares of ABBV (ABBVIE INC), valued at $7.99M, representing 0.60% of its reported portfolio and ranking #39.

Has Kimelman & Baird, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Kimelman & Baird, LLC held unchanged its position in ABBV. The position peaked in Q3 2026 at 30.56K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.